Skip to main content
Medical Affairs
Our Company
Who We Are
Leadership
Focus Areas
Overview
Oncology
Immunology & Inflammation
Neurology
Pipeline
Ongoing Clinical Trials
Presentations & Publications
Patients & Care Partners
Expanded Access
Healthcare Professionals (Coming soon!)
Our Medicines
Join Us
Our Culture
Open Positions
News
Ono Pharma
ONO-4685
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma (NCT05079282)
Oncology
Disease/Condition: Relapsed/Refractory T-Cell Lymphoma
Back to top
